Latest posts
-
CBD Tolerance and Dosing: Why Effects May Change Over Time
By TakeHempGummies.com Consumer Research Desk Why Does CBD Seem to Work Differently Over Time? Many CBD users notice that a product that once felt strong seems milder after weeks or months of regular use. This can happen for several reasons: how your body processes CBD, how consistent the product’s actual potency is, and general changes…
-
Delta-8 THC: Legal Status, Safety Concerns and How It Differs From Delta-9
By TakeHempGummies.com Consumer Research Desk Quick Answer Delta-8 THC is a psychoactive cannabinoid that is chemically similar to delta-9 THC (the compound that causes marijuana’s “high”) but is usually made from hemp-derived CBD through a chemical conversion process. The FDA has not evaluated or approved delta-8 THC products for safe use in any context, and…
-
CBD and Anxiety: Clinical Trial Evidence, Limitations and What Remains Unknown
By TakeHempGummies.com Consumer Research Desk What the research actually shows Clinical trials on CBD and anxiety show mixed but promising results. Some randomized controlled trials find CBD lowers anxiety symptoms compared to a placebo. Others find little or no difference. Researchers agree that the studies done so far are too small, too short, and too…
-
Hemp Gummy Lab Testing: How to Read Certificates of Analysis and Spot Red Flags
By TakeHempGummies.com Consumer Research Desk What a Certificate of Analysis Tells You A Certificate of Analysis, or COA, is a lab report that shows what’s actually inside a hemp gummy. It lists the cannabinoids the lab found, how much of each one, and whether contaminants like pesticides or heavy metals showed up. Reading it takes…
-
CBG: The Parent Cannabinoid and What Early Research Suggests
By TakeHempGummies.com Consumer Research Desk What Is CBG, and Why Do People Call It the “Parent Cannabinoid”? Cannabigerol, or CBG, is a non-intoxicating compound found in the cannabis and hemp plant. Researchers call it the “parent cannabinoid” because its acidic form, CBGA, is the starting molecule that the plant converts into THC and CBD as…
-
CBD and Sleep Research: Clinical Evidence, Dose Ranges and What Studies Actually Show
By TakeHempGummies.com Consumer Research Desk What CBD and Sleep Research Actually Shows CBD has been studied for sleep, but the evidence is still limited. The largest study on CBD and sleep found that most people reported better sleep scores within a month, but the study did not use a control group, and the improvement did…
-
Full Spectrum vs Broad Spectrum vs CBD Isolate: What the Terms Mean and Why It Matters
By TakeHempGummies.com Consumer Research Desk Full Spectrum, Broad Spectrum, or Isolate? The Short Answer These three terms describe how much of the hemp plant stays in a CBD product after processing. Full spectrum keeps nearly everything the plant naturally produces, including trace THC. Broad spectrum keeps most of those compounds but has THC removed or…
-
CBD and Hormones: What Research Exists on Cortisol, Testosterone and Thyroid
By TakeHempGummies.com Consumer Research Desk What Does Research Say About CBD and Hormones? Right now, research on CBD and hormones is limited. Most of what we know comes from animal studies, lab experiments, or small human trials, not large clinical research. Early findings suggest CBD may interact with the body’s stress-hormone system (cortisol) and, in…
-
Hemp Gummy Bioequivalence: Why Different Brands at the Same Dose Feel Different
By TakeHempGummies.com Consumer Research Desk Why Two “25mg CBD” Gummies Can Feel Completely Different Two hemp gummies can both say “25mg CBD” on the label and still produce different effects. This happens because the printed number is a label claim, not a commitment of what’s actually in the gummy, and because the type of hemp…
-
Endocannabinoid Deficiency Theory: What It Claims, Who Proposed It and What Evidence
By TakeHempGummies.com Consumer Research Desk What Is the Endocannabinoid Deficiency Theory? The endocannabinoid deficiency theory, sometimes called clinical endocannabinoid deficiency or CECD, is a hypothesis proposed by a neurologist that some hard-to-treat conditions may be linked to low levels of the body’s own cannabinoid-like chemicals. It is not a confirmed medical diagnosis. No blood test,…